• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Cory Jubinville Maintains Mereo Biopharma Group Plc Buy Rating with $9 Price Target
14:17
Gil Blum Maintains 'Buy' Rating on Mereo Biopharma with $5.00 Price Target
10:06
Mereo Biopharma released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 4.971M), actual EPS USD -0.0439 (forecast USD -0.0053)
04:00
Mereo Biopharma released FY2025 9 Months earnings on November 10 (EST), actual revenue USD 500K, actual EPS USD -0.2235
04:00
Aug13
Mereo Biopharma released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 500K, actual EPS USD -0.1731 (forecast EPS USD -0.0202)
03:00
Mereo Biopharma released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 500K (forecast USD 0), actual EPS USD -0.0914 (forecast USD -0.0118)
03:00

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.024 M, EPS -0.0439

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 500 K, Net Income -14.62 M, EPS -0.0914

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -12.89 M, EPS -0.0821

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
386.260
+173.94%
+245.260
WHLR
6.640
+104.94%
+3.390
GURE
9.290
+95.99%
+4.480
TGL
12.710
+88.07%
+5.952
TDIC
0.4005
+42.63%
+0.118
IRBT
4.210
+38.94%
+1.187
PRAX
252.220
+32.77%
+62.250
CLIK
7.440
+30.53%
+1.740
DBRG
12.585
+29.48%
+2.875
TORO
5.300
+28.33%
+1.141
View More